Biogen Inc
NASDAQ: BIIB
$143.54
+$4.10 (+2.9%)
Closing Price on March 17, 2025
BIIB Articles
24/7 Wall St. has taken a look at some of the largest biotech companies and highlighted the damage that a single tweet did to them last week.
Published:
The September 15 short interest data have been compared with the previous figures, and short interest in these selected stocks increased across the board for this settlement date.
Published:
In a new and very comprehensive report, Jefferies starts coverage on biotechs with some very targeted stock selections.
Published:
The short interest data are out for the August 31 settlement date. Short interest in the selected biotech stocks increased across the board for this settlement date.
Published:
ThinkstockAre biotech companies going to become the next big companies saddled with debt? Most likely not, but two debt offerings will stand out to investors here. The first was a $10 billion...
Published:
The short interest data are out for the August 14 settlement date. Biotech companies are considered a riskier group of stocks.
Published:
Applied Genetic Technologies announced that the Biogen equity investment as part of their collaboration has closed.
Published:
The short interest data are out for the July 31 settlement date, and overall, short interest in the selected biotech stocks backed off for this period.
Published:
It may be impossible to ever know if a true bottom has ever been seen, but many investors love finding great companies where they feel that a sell-off has overly punished the share price.
Published:
Tuesday's top analyst upgrades, downgrades and initiations include Adobe, Biogen, Google, PDC Energy, Rackspace and XL Group.
Published:
Merrill Lynch has looked at large cap biotech leaders and how interest rate increases may play a part in stock performance.
Published:
ThinkstockThere are times when a negative piece of news in the BioPharma sector can actually help rival companies. Biogen Inc. (NASDAQ: BIIB) is a stock that has been battered of late, and it is a...
Published:
In a new research report, Cowen's well-respected analyst Ken Cacciatore makes a very good case that some huge, high-profile biotech companies could be targeted for buyouts.
Published:
ThinkstockNothing like earnings season coming around to buy stock if you are an insider and your company happens to disappoint. While most of the S&P 500 companies have reported as August begins,...
Published:
Jon OggStocks were indicated lower by almost 1% on Monday after China’s Shanghai market suffered its biggest loss in about 8 years on Monday. The one trend that has held up for almost 4 years now...
Published:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.